Levin Capital Strategies L.P. Takes $382,000 Position in Eli Lilly and Company (NYSE:LLY)
Levin Capital Strategies L.P. acquired a new stake in Eli Lilly and Company (NYSE:LLY – Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 815 shares of the company’s stock, valued at approximately $382,000. Several other institutional investors […]